SCHEMBL30168823

SCHEMBL30168823

C1=NC2=Nc3ccccc3C2=C1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905893 1.00 IDO1 (0.33) IDO1
SCHEMBL27840600 0.98 IDO1 (0.32) IDO1
Glyoxylate SCHEMBL2364947 0.85 IDO1 (0.33) IDO1
SCHEMBL29941302 0.85 MEN1 (0.39)
SCHEMBL29352286 0.75 MAPT (0.40) IDO1
SCHEMBL1120300 0.75 MAPT (0.40) IDO1
SCHEMBL3226013 0.73 IDO1 (0.37) IDO1
SCHEMBL27849362 0.68 IDO1 (0.34) IDO1
SCHEMBL28942884 0.68 IDO1 (0.32) IDO1
SCHEMBL28439324 0.67 IDO1 (0.31) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042736-A1 COMPOSITIONS AND METHODS FOR MAKING SCYTONEMIN AND ITS ANALOGS AND DERIVATIVES Board of Regents of Nevada System of Higher Education on behalf of the University of Nevada Reno (US) 2026-02-12 US disclosed
CN-121137626-A Process for preparing pyrrolo [2,3-b ] indole derivatives 宁夏医科大学 2025-12-16 CN disclosed
CN-121137626-A Process for preparing pyrrolo [2,3-b ] indole derivatives 宁夏医科大学 2025-12-16 CN disclosed
CN-120574236-A Pyrrolo [2,3-b ] indole compound and preparation method and application thereof 上海大学 2025-09-02 CN disclosed
CN-120574236-A Pyrrolo [2,3-b ] indole compound and preparation method and application thereof 上海大学 2025-09-02 CN disclosed
CN-115667541-A Methods of diagnosing and treating leukemia 大原药品工业株式会社 2023-01-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042736-A1 COMPOSITIONS AND METHODS FOR MAKING SCYTONEMIN AND ITS ANALOGS AND DERIVATIVES TDO2, SCO2, TPH1 IDO1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.